On July 20, New China Life Insurance rose 3.05% in regular trading, trading at HK$46.18/share, with turnover of HK$109 million. The stock exhibited a recovery pattern following its 3.25% decline on July 17.
On the news front, the domestic insurance sector rallied broadly, with China Taiping up 5.41%, Ping An up 2.47%, and China Life up 2.27%, reflecting significant sector linkage. The prior session's weakness was attributed to BlackRock reducing its H-share stake from 5.23% to 4.94% on July 10, falling below the 5% disclosure threshold, and UBS cutting its target price to HK$45.5 on July 14.
Underpinning the recovery, New China Life Insurance issued an H1 earnings pre-announcement on July 13 forecasting attributable net profit of RMB 20.72 billion to RMB 23.68 billion, representing 40% to 60% year-over-year growth. The company cited value growth in its life insurance business, enhanced investment capabilities, and optimized asset allocation. Bocom International raised its target price to HK$59, while Citi added the stock to its 30-day positive catalyst watch with a HK$50.2 target.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments